Etrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7)

Catalog No.A2856

Clone No.

Technical Data

CAS No.	1044758-60-2
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype	Human IgG1
Source	CHO
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Biological Activity

Description	Etrolizumab (Anti-Integrin a4b7) (ITGA4 & ITGB7) is a gut‐selective humanized monoclonal antibody targets β7 integrins with a potential to treat inflammatory bowel disease (IBD). MW: 144.3 KD.

References	[1] Tang MT, et al. Aliment Pharmacol Ther. 2018;47(11):1440-1452.

References

[1] Tang MT, et al. Aliment Pharmacol Ther. 2018;47(11):1440-1452.

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.